These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


2063 related items for PubMed ID: 27715439

  • 1. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J, Huang KY, Zhu Y, Pan JW, Jiang H, Weng YX, Zhan RY.
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J, Shen J, Zhu K, Zhou H, Tian H, Yu G.
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [Abstract] [Full Text] [Related]

  • 3. Statin-treated patients with aneurysmal subarachnoid haemorrhage: a meta-analysis.
    Zhu RL, Chen ZJ, Li S, Lu XC, Tang LJ, Huang BS, Yu W, Wang X, Qian TD, Li LX.
    Eur Rev Med Pharmacol Sci; 2016 May; 20(10):2090-8. PubMed ID: 27249609
    [Abstract] [Full Text] [Related]

  • 4. Dose-Dependent Effects of Statins for Patients with Aneurysmal Subarachnoid Hemorrhage: Meta-Regression Analysis.
    To MS, Prakash S, Poonnoose SI, Bihari S.
    World Neurosurg; 2018 May; 113():153-162. PubMed ID: 29425980
    [Abstract] [Full Text] [Related]

  • 5. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.
    Parra A, Kreiter KT, Williams S, Sciacca R, Mack WJ, Naidech AM, Commichau CS, Fitzsimmons BF, Janjua N, Mayer SA, Connolly ES.
    Neurosurgery; 2005 Mar; 56(3):476-84; discussion 476-84. PubMed ID: 15730572
    [Abstract] [Full Text] [Related]

  • 6. Dissociation of vasospasm-related morbidity and outcomes in patients with aneurysmal subarachnoid hemorrhage treated with clazosentan: a meta-analysis of randomized controlled trials.
    Shen J, Pan JW, Fan ZX, Xiong XX, Zhan RY.
    J Neurosurg; 2013 Jul; 119(1):180-9. PubMed ID: 23641823
    [Abstract] [Full Text] [Related]

  • 7. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [Abstract] [Full Text] [Related]

  • 8. Effect of Statins on Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.
    Zhang BF, Song JN, Wang J, Ma XD, Zhang ST, Zhao JJ, Shu K, Sun P, Zhao YL.
    Turk Neurosurg; 2015 Jan; 25(6):850-7. PubMed ID: 26617132
    [Abstract] [Full Text] [Related]

  • 9. Effect of simvastatin in patients with aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Liu H, Xu X.
    Am J Emerg Med; 2017 Dec; 35(12):1940-1945. PubMed ID: 28966073
    [Abstract] [Full Text] [Related]

  • 10. Effect of statin treatment on vasospasm, delayed cerebral ischemia, and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis update.
    Vergouwen MD, de Haan RJ, Vermeulen M, Roos YB.
    Stroke; 2010 Jan; 41(1):e47-52. PubMed ID: 19875741
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Do statins improve outcomes and reduce the incidence of vasospasm after aneurysmal subarachnoid hemorrhage: a meta-analysis.
    Sillberg VA, Wells GA, Perry JJ.
    Stroke; 2008 Sep; 39(9):2622-6. PubMed ID: 18658040
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial.
    Naraoka M, Matsuda N, Shimamura N, Asano K, Akasaka K, Takemura A, Hasegawa S, Ohkuma H.
    J Cereb Blood Flow Metab; 2018 Jul; 38(7):1190-1198. PubMed ID: 28762878
    [Abstract] [Full Text] [Related]

  • 16. Effect of clazosentan in patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials.
    Wang X, Li YM, Li WQ, Huang CG, Lu YC, Hou LJ.
    PLoS One; 2012 Jul; 7(10):e47778. PubMed ID: 23082215
    [Abstract] [Full Text] [Related]

  • 17. Thick and diffuse cisternal clot independently predicts vasospasm-related morbidity and poor outcome after aneurysmal subarachnoid hemorrhage.
    Aldrich EF, Higashida R, Hmissi A, Le EJ, Macdonald RL, Marr A, Mayer SA, Roux S, Bruder N.
    J Neurosurg; 2021 May 01; 134(5):1553-1561. PubMed ID: 32442971
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 104.